**Correction to**: *npj Breast Cancer*; 10.1038/npjbcancer.2016.17, Published online 8 June 2016

In the original version of the published article, line three of the third paragraph of the methods stated "Excluding patients with micrometastatic disease, the 5-year BCSM for patients with Recurrence Score results \<18 and 1--3 positive nodes (*n* = 2,617) was 1.3% (95% CI, 0.6--2.9%)." To improve clarity this statement has been replaced with "Excluding patients with micrometastatic disease, there were 2,617 patients with 1--3 positive nodes. Of these, 1,487 also had Recurrence Score results \<18 with 5-year BCSM of 1.3% (95% CI, 0.6--2.9%)." The original version of the published article also contained an error in the second sentence of the Figure 2 legend describing the mutation status of the patient population examined. The sentence in the original published version of the Article stated "Patients with HR+, HER2-positive, node-negative..." this has been changed to "Patients with HR+, HER2-negative, node-negative...". This has been corrected in the PDF and HTML versions of this paper.
